Published in Cancer Weekly, May 16th, 2000
The initial results of this study were reported by I. Ganly et al. in Clinical Cancer Research ("A Phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer," Clin Cancer Res, 2000;6(3):798-806).
Twenty-two patients were given an intratumor injection of Onyx-015. Twenty-one of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.